Sort
23,748 grants matching “melanoma”
Preclinical Therapeutics
$271,812Frank Patrick McCormick · University Of California, San Francisco · P30 · FY2012 · CA
Control of cancer and metastasis by endothelial-derived epoxyeicosatrienoic acids
$271,769Dipak Panigrahy · Beth Israel Deaconess Medical Center · R01 · FY2014 · CA
Bioinformatics, Biostatistics, and Image Analyses Core
$271,674Xiaole Shirley Liu · Massachusetts General Hospital · P01 · FY2021 · CA
Bioinformatics, Biostatistics, and Image Analyses Core
$271,674Xiaole Shirley Liu · Massachusetts General Hospital · P01 · FY2020 · CA
Mechanical regulation of the microenvironmental niche in skin tumorigenesis
$271,642Kandice Tanner · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Project 2: Design and Development of Third Generation RXR Rexinoids as Potential Chemoprevention Agents
$271,589Matthew B Renfrow · University Of Alabama At Birmingham · P01 · FY2020 · CA
GENETIC MODIFICATION OF HUMAN DENDRITIC CELLS FOR CANCER IMMUNITY
$271,531James W. Young · Sloan-Kettering Inst Can Research · R01 · FY2012 · CA
Removing sialic acid ligands of CD28 to enhance T cell cancer immunotherapy
$271,500James C. Paulson · Scripps Research Institute, The · R21 · FY2024 · AI
NOVEL APPROACAHES FOR IMPROVING PEDIATRIC BRAFV600E GLIOMA PATIENT OUTCOMES
$271,490Charles David James · University Of California, San Francisco · P50 · FY2013 · CA
Multi-Peptide/IL 12 Melanoma Vaccine
$271,450University Of Chicago · R01 · FY2004 · CA
Multi-Peptide/IL 12 Melanoma Vaccine
$271,450University Of Chicago · R01 · FY2005 · CA
Multi-Peptide/IL 12 Melanoma Vaccine
$271,450University Of Chicago · R01 · FY2003 · CA
MECHANISMS OF DIETARY MODULATION OF MELANOMA INVASION
$271,410Washington State University · R01 · FY2002 · CA
ACTIVITIES OF BETA CATENIN AND LEF/TCF COMPLEXES
$271,365University Of California Irvine · R01 · FY2000 · CA
Molecular Signatures of Melanoma: Predicting Response to Therapy & Targeting
$271,316Todd R. Golub · Brigham And Women'S Hospital · P50 · FY2011 · CA
Light-responsive ruthenium compounds for applications in disease
$271,300Edith C Glazer · University Of Kentucky · R01 · FY2014 · GM
Optimization of Melanoma Vaccines with T-Helper Epitopes
$271,233Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · CA
Optimization of Melanoma Vaccines with T-Helper Epitopes
$271,233Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2010 · CA
Inhibition of Cytochrome c-induced Caspase Activation
$271,190Sally A Kornbluth · Duke University · R01 · FY2010 · CA
AUTOLOGOUS HAPTEN MODIFIED VACCINE FOR HUMAN CANCER
$271,176Thomas Jefferson University · R01 · FY2001 · CA
Cell-based tumor vaccines targeting CD4+ T lymphocytes
$271,170Suzanne Ostrand-Rosenberg · University Of Maryland Baltimore County · R01 · FY2009 · CA
Cell-based tumor vaccines targeting CD4+ T lymphocytes
$271,147Suzanne Ostrand-Rosenberg · University Of Maryland Baltimore County · R01 · FY2010 · CA
Biorepository and Molecular Pathology (BMP)
$271,130Gary Christopher Fillmore · University Of Utah · P30 · FY2023 · CA
OVERCOMING TUMOR EVASION MECHANISMS IN HODGKIN DISEASE
$271,113Cliona M Rooney · Baylor College Of Medicine · P01 · FY2012 · CA
Malignant melanoma: Regulation by AP-2 and PAR-1
$271,063Menashe Bareli · University Of Tx Md Anderson Can Ctr · R01 · FY2008 · CA